Trials / Completed
CompletedNCT01053559
Assessment of Small Bowel Healing in Crohn's Disease Patients Treated With Cimzia Using Wireless Capsule Endoscopy
Open Label Investigator Initiated, Single Site Study of Mucosal Healing in Patients With Small Bowel Crohn's Disease Treated With Certolizumab Pegol (Cimzia) Assessed by Wireless Capsule Endoscopy
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 15 (actual)
- Sponsor
- Shafran Gastroenterology Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Wireless Capsule Endoscopy has been the most reliable diagnostic standard for small bowel Crohn's disease. Endoscopic healing is an important endpoint to measure response to treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | certolizumab pegol | 400mg subcutaneous injections at week 0, week 2, week 4, then every 4 weeks thereafter |
Timeline
- Start date
- 2010-01-01
- Primary completion
- 2013-09-01
- Completion
- 2013-09-01
- First posted
- 2010-01-21
- Last updated
- 2014-04-24
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01053559. Inclusion in this directory is not an endorsement.